RecruitingNCT04664556

National, Non Interventional Study of Invasive Pneumococcal Disease in Children and Newborns

Population-based Nationwide Study on Invasive Pneumococcal Infections Among Children (0-18 Years) in France


Sponsor

Association Clinique Thérapeutique Infantile du val de Marne

Enrollment

2,500 participants

Start Date

Dec 13, 2010

Study Type

OBSERVATIONAL

Conditions

Summary

After 7 then 13 valent pneumococcal conjugate vaccine (PCV) implementation in France in children, we will evaluate the impact of this vaccination on invasive pneumococcal disease (IPD). We will describe the clinical characteristics of IPD, pneumococcus serotyping, underlying conditions and vaccination status.


Eligibility

Min Age: 1 DayMax Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with antibiotic treatment, mortality, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 1 Day to 18 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

ACTIV

Créteil, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04664556


Related Trials